Daratumumab With DCEP for Multiple Myeloma With Plasmacytoma
Clinical trial NCT04065308 · UNKNOWN
Trial details
- NCT number
- NCT04065308
- Sponsor
- Seoul National University Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-14
- Primary completion
- 2019-12-21
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.